Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2021;6(1):1838.DOI: 10.25107/2474-1663-v6-id1838

Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Microcalcifications: A Study Based on the 5th Edition of BI-RADS

Ran Luo, Lijun Wang, Dengbin Wang, Yuzhen Zhang and Yanhong Chen

Department of Radiology, Shanghai Jiao Tong University School of Medicine, China

*Correspondance to: Dengbin Wang 

 PDF  Full Text Research Article | Open Access

Abstract:

Objective: To investigate whether breast MR imaging could help in differentiating malignant from benign mammographic microcalcifications.
Methods: The study consecutively included 106 patients with 112 mammographic microcalcifications between January 2014 and April 2017 in our institute. Pre-operative mammograms and breast MR images were analyzed in a blind manner by two trained breast imaging subspecialists. Each lesion was described and categorized according to the 5th BI-RADS atlas. AUC, sensitivity, specificity, positive Likelihood Ratio (LR) were used to evaluate the value of MR imaging in differentiating malignancy from benignity.
Results: Of the 112 lesions, pathologic results revealed 81 benign, 12 pre-cancerous and 19 malignant (10 invasive cancer and 9 ductal carcinoma in situ) findings. The number of lesions assigned to BIRADS 3, 4B, 4C, and 5 was 2, 92, 16, and 2, respectively, resulting in a PPV of 14.7% (17/108) for MG-BI-RADS 4 microcalcifications. The number of MRI classification 1 to 5 to the corresponding BI-RADS 4B microcalcifications were 37, 2, 33, 27, and 9 respectively. MR-BI-RADS criteria ruled out 72 benign MG-BI-RADS 4 lesions with none malignancy missed, while MRI enhancement criteria ruled out 46 benign lesions. MR-BI-RADS criteria were significantly better in AUC (0.896, P<0.0001), specificity (79.12%, P<0.0001), and positive LR (4.79) than mammography and MRI enhancement criteria. Conclusion: Breast MR imaging is useful in the evaluation of BI-RADS 4 mammographic microcalcifications by avoiding 79.12% unnecessary biopsies with none false-negative diagnosis.

Keywords:

Breast; Microcalcification; Magnetic resonance imaging; Clinical decision-making

Cite the Article:

Luo R, Wang L, Wang D, Zhang Y, Chen Y. Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Microcalcifications: A Study Based on the 5th Edition of BIRADS. Clin Oncol. 2021;6:1838..

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Loss of EAF2 Facilitates Pancreatic Cancer Progression via Inhibiting the Apoptosis of the Neoplastic Cells
 Abstract  PDF  Full Text
Primary Uveal Lymphoma: Report of Three Cases with Histopathology Proven
 Abstract  PDF  Full Text
View More...